151,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 6-10 Tagen
payback
76 °P sammeln
  • Gebundenes Buch

This book describes microRNAs as relevant tools that form a new bridge in modern oncological progress between molecular insights and clinical practice. It also highlights the therapeutic applications, emphasizing their utility in personalized medicine and targeted therapies.
MicroRNAs (miRNAs) are short, non-coding RNAs that play a crucial role in regulating gene expression. Their importance in cancer biology has grown significantly in recent years, as they have been found to influence various aspects of cancer development and progression. This book provides a comprehensive overview of the…mehr

Produktbeschreibung
This book describes microRNAs as relevant tools that form a new bridge in modern oncological progress between molecular insights and clinical practice. It also highlights the therapeutic applications, emphasizing their utility in personalized medicine and targeted therapies.

MicroRNAs (miRNAs) are short, non-coding RNAs that play a crucial role in regulating gene expression. Their importance in cancer biology has grown significantly in recent years, as they have been found to influence various aspects of cancer development and progression. This book provides a comprehensive overview of the diverse roles of miRNAs in several cancers, from their biogenesis and functions to their potential as therapeutic targets and biomarkers. This book further looks into the critical role of the miRNAs in the tumor microenvironment (TME) and their influence on processes such as epithelial-to-mesenchymal transition, immune modulation, and angiogenesis. The chapters focus on their diagnostic and therapeutic importance in several cancer types, such as colorectal, cervical, lung, and breast cancers, with particular emphasis on cancers that exhibits unusual metastatic patterns such as breast and prostate cancer metastasis to bones. The chapters will additionally address the process by which miRNA-mediated pathways contribute to the development of brain and gynaecological tumors, as well as explores the potential of exosomal miRNAs as non-invasive biomarkers for cancer detection through mechanisms that trigger intracellular signaling within the TME.

The development of AI and bioinformatics has transformed miRNA research, enabling a deeper understanding of miRNA function and facilitating the development of innovative diagnostic and therapeutic strategies. By incorporating them into high-throughput sequencing with machine learning approaches, several models have been developed that have favoured the identification, classification, and prediction of the target functions of miRNAs and their targets, particularly in cancer biology.
Autorenporträt
Prof. Surajit Pathak, Ph.D., is a leading researcher and academic, currently a Professor at Chettinad Academy of Research and Education in Chennai. He has previously held esteemed positions as Principal Research Scientist at Linkoping University, Sweden, With a Ph.D. from India (2007) and an extensive post-doctoral journey at renowned institutions like the University of Alabama (USA), University of Padova (Italy), and University of Linkoping (Sweden), his research focuses on microRNAs for early colorectal cancer detection. Prof. Pathak has published over 150 research and review articles, earning more than 5000 citations and an h-index of 39. Prof. Pathak is a member of national research societies.      Prof. Antara Banerjee, Ph.D., is currently working as a Professor at Chettinad Academy of Research and Education (CARE), Chennai. Dr. Banerjee pursued her post-doctoral research on Cancer Biology and Regenerative Medicine at the University of Padova, Italy, and Linkoping University. She has published over 120 articles with an h-index of 34 and 3804 citations (Google scholar) with 2 patents awarded and 5 filed and secured national and international grants. Dr. Banerjee has edited several books on Stem Cells and Cancer. She is affiliated with professional research bodies and is a member of several national research societies.